1-(carboxymethylthio)tetradecane has been researched along with interleukin-8 in 2 studies
| Studies (1-(carboxymethylthio)tetradecane) | Trials (1-(carboxymethylthio)tetradecane) | Recent Studies (post-2010) (1-(carboxymethylthio)tetradecane) | Studies (interleukin-8) | Trials (interleukin-8) | Recent Studies (post-2010) (interleukin-8) |
|---|---|---|---|---|---|
| 143 | 5 | 32 | 23,523 | 1,167 | 9,990 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aukrust, P; Berge, RK; Damås, JK; Dyrøy, E; Halvorsen, B; Ueland, T; Yndestad, A | 1 |
| Aukrust, P; Berge, RK; Bohov, P; Livden, JK; Morken, T; Skorve, J; Ulvik, R | 1 |
1 trial(s) available for 1-(carboxymethylthio)tetradecane and interleukin-8
| Article | Year |
|---|---|
Anti-inflammatory and hypolipidemic effects of the modified fatty acid tetradecylthioacetic acid in psoriasis--a pilot study.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Double-Blind Method; Female; Humans; Hypolipidemic Agents; Interleukin-8; Lipids; Male; Middle Aged; Pilot Projects; Psoriasis; Sulfides; Tumor Necrosis Factor-alpha; Vascular Cell Adhesion Molecule-1; Young Adult | 2011 |
1 other study(ies) available for 1-(carboxymethylthio)tetradecane and interleukin-8
| Article | Year |
|---|---|
Antiinflammatory effects of tetradecylthioacetic acid involve both peroxisome proliferator-activated receptor alpha-dependent and -independent pathways.
Topics: Adult; Aged; Animals; Anti-Inflammatory Agents; Antioxidants; Cell Adhesion; Cells, Cultured; Chemokine CCL2; Endothelium, Vascular; Female; Gene Expression; Humans; Interleukin-8; Male; Mice; Mice, Inbred Strains; Mice, Mutant Strains; Middle Aged; Monocytes; Neutrophils; PPAR alpha; PPAR delta; Psoriasis; Sulfides; Tumor Necrosis Factor-alpha; Umbilical Veins; Vascular Cell Adhesion Molecule-1 | 2005 |